Longhou Fang

Dr. Longhou Fang received his doctoral degree from the Shanghai Institute of Biochemistry and Cell Biology, CAS. He completed postdoctoral research at the University of California, San Diego. Dr. Longhou Fang is currently a Associate Professor of Cardiovascular Sciences, Academic Institute Associate Member, Research Institute Houston Methodist Weill Cornell Medical College. The Fang lab employ zebrafish and mouse models to studying the role of lipid metabolism in angiogenesis and lymphangiogenesis. During his postdoctoral studies at UC San Diego, Dr. Fang discovered that apolipoprotein (apoA-I) binding protein (AIBP) controls angiogenesis via regulation of cholesterol homeostasis.Based upon the findings, the Fang laboratory will be focusing on the role of AIBP-regulated lipid metabolism in angiogenesis and lymphangiogenesis. We will use a plethora of disease models such as heart hypertrophy, heart ischemia and reperfusion, peripheral artery ischemia and reperfusion, corneal angiogenesis, and tumorigenesis in mice as well as in zebrafish heart regeneration. Both zebrafish and mouse model will be used to study the role of AIBP in lymphangiogenesis.

Lab Information

Houston Methodist, Weill Cornell Medical College

Research Area and Skills

Recognize this scientist’s Expertise for their contribution in your research

Angiogenesis 0 Lymphangiogenesis 0 Hematopoiesis 0 Cholesterol metabolism 0

More

  • Post
  • Publication
  • Plasmid
  • Following (0)
  • Follower (1)


This guy hasn’t posted anything yet.

Hot Posts for You

Neutralizing antibodies (NAbs) are critical human immune defense mechanisms against viral infections. NAbs can bind to sites on the virus and inhibit entry of that virus into the host. It is a key parameter to evaluate COVID-19 vaccine efficacy per Guidelines from Development and ...Learn More


This 3D animation shows you how DNA is copied in a cell. It shows how both strands of the DNA helix are unzipped and copied to produce two identical DNA molecules. TranscriptDNA is a molecule made up of two strands twisted around each other in a double helix shape. Each strand is ...Learn More


IntroductionA gleam of light finally shone down on the global crisis of the prolonged battle against COVID-19, giving people hopes of preventive care and treatment in the near future by monoclonal antibodies against SARS-CoV-2. As stated the news of NIH’s phase III clinical ...Learn More


"Those who do not know history are obliged to repeat it" This famous phrase that could be from any history teacher to his suspended students has been attributed to great figures in history such as Napoleon or the philosopher George Santayana. In a modern version of it we could say ...Learn More


In recent years there is an increasing number of cytotoxic chemotherapeutic compounds with the ability to rapidly kill dividing cancer cells in preference to non-dividing healthy cells. Nevertheless, the major drawback of chemotherapy is that, in addition to damaging the cancer ...Learn More


The coronavirus pandemic caught everyone unprepared. We had to deal with the fear of an unknown virus which can be lethal for some people. And the whole world just stopped in an attempt to prevent the virus spread.Suddenly we had to adapt to a new way of living, socially isolated ...Learn More


This is the first episode of MolecularCloud Pioneer Scientist interview series. In this interview, MolecularCloud talks with Prof. Shuo Huang from Nanjing University about the recent publications of Dr. Huang’s team and the future prospect of biological nanopore technology. The ...Learn More


The increasing number of confirmed COVID-19 cases is prompting an unprecedented global effort to find a treatment for the disease. Given the fact that a new drug development could be a decade work from initial discovery to the marketplace, scientists are racing to search a cure ...Learn More


The previous article on precision medicine was focused on Pharmacogenomics as a fundamental aspect of cancer therapeutics. In this sequel, emphasis would be on the role of immuno-oncology in personalization of cancer therapy, citing anti PD therapy as an example with hypothetical ...Learn More


  1. Combination of apolipoprotein-A-I/apolipoprotein-A-I binding protein and anti-VEGF treatment overcomes anti-VEGF resistance in choroidal neovascularization in mice

  2. Zhu, L, Parker, M, Enemchukwu, N, Shen, M, Zhang, G, Yan, Q, Handa, JT, Fang, L & Fu, Y 2020, , Communications Biology, vol. 3, no. 1, 386.

  3. Hematopoiesis is regulated by cholesterol efflux pathways and lipid rafts: Connections with cardiovascular diseases

  4. Morgan, PK, Fang, L, Lancaster, GI & Murphy, AJ 2020, , Journal of lipid research, vol. 61, no. 5, pp. 667-675.

  5. Regulation of lipid rafts, angiogenesis and inflammation by AIBP

  6. Fang, L & Miller, YI 2019, , Current opinion in lipidology, vol. 30, no. 3, pp. 218-223.

  7. 4. AIBP-mediated cholesterol efflux instructs hematopoietic stem and progenitor cell fate

  8. Gu, Q, Yang, X, Lv, J, Zhang, J, Xia, B, Kim, JD, Wang, R, Xiong, F, Meng, S, Clements, TP, Tandon, B, Wagner, DS, Diaz, MF, Wenzel, PL, Miller, YI, Traver, D, Cooke, JP, Li, W, Zon, LI, Chen, K, Bai, Y & Fang, L 2019, , Science, pp. eaav1749.

  9. 5. TBX20 Regulates Angiogenesis Through the Prokineticin 2-Prokineticin Receptor 1 Pathway

  10. Meng, S, Gu, Q, Yang, X, Lv, J, Owusu, I, Matrone, G, Chen, K, Cooke, JP & Fang, L 2018, , Circulation, vol. 138, no. 9, pp. 913-928.

  11. 6. AIBP augments cholesterol efflux from alveolar macrophages to surfactant and reduces acute lung inflammation

  12. Choi, SH, Wallace, AM, Schneider, DA, Burg, E, Kim, J, Alekseeva, E, Ubags, ND, Cool, CD, Fang, L, Suratt, BT & Miller, YI 2018, , JCI insight, vol. 3, no. 16.

  13. 7. AIBP protects against metabolic abnormalities and atherosclerosis

  14. Schneider, DA, Choi, SH, Agatisa-Boyle, C, Zhu, L, Kim, J, Pattison, J, Sears, DD, Gordts, PLSM, Fang, L & Miller, YI 2018, , Journal of lipid research, vol. 59, no. 5, pp. 854-863.

  15. 8. A minimally invasive approach to induce myocardial infarction in mice without thoracotomy

  16. Sun, Q, Wang, KK, Pan, M, Zhou, JP, Qiu, XT, Wang, ZY, Yang, Z, Chen, Y, Shen, H, Gu, QL, Fang, LH, Zhang, GG & Bai, YP 2018, , Journal of Cellular and Molecular Medicine, vol. 22, no. 11, pp. 5208-5219. https://doi.org/10.1111/jcmm.13708

  17. 9. Lmo2 (LIM-Domain-Only 2) Modulates Sphk1 (Sphingosine Kinase) and Promotes Endothelial Cell Migration

  18. Matrone, G, Meng, S, Gu, Q, Lv, J, Fang, L, Chen, K & Cooke, JP 2017, , Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 37, no. 10, pp. 1860-1868.

  19. 10. AIBP Limits Angiogenesis Through ?-Secretase-Mediated Upregulation of Notch Signaling

  20. Mao, R, Meng, S, Gu, Q, Araujo-Gutierrez, R, Kumar, S, Yan, Q, Almazan, F, Youker, KA, Fu, Y, Pownall, HJ, Cooke, JP, Miller, YI & Fang, L 2017, , Circulation Research, vol. 120, no. 11, pp. 1727-1739.

  21. 11. AIBP: A Novel Molecule at the Interface of Cholesterol Transport, Angiogenesis, and Atherosclerosis

  22. Zhu, L & Fang, L 2015, , Methodist DeBakey cardiovascular journal, vol. 11, no. 3, pp. 160-165.

  23. 12. Polo-like kinase 2 regulates angiogenic sprouting and blood vessel development

  24. Yang, H, Fang, L, Zhan, R, Hegarty, JM, Ren, J, Hsiai, TK, Gleeson, JG, Miller, YI, Trejo, JA & Chi, NC 2015, , Developmental Biology, vol. 404, no. 2, pp. 49-60.

  25. 13. Apoc2 loss-of-function zebrafish mutant as a genetic model of hyperlipidemia

  26. Liu, C, Gates, KP, Fang, L, Amar, MJ, Schneider, DA, Geng, H, Huang, W, Kim, J, Pattison, J, Zhang, J, Witztum, JL, Remaley, AT, Dong, PD & Miller, YI 2015, , DMM Disease Models and Mechanisms, vol. 8, no. 8, pp. 989-998.

  27. 14. Oxidative stress activates endothelial innate immunity via sterol regulatory element binding protein 2 (SREBP2) transactivation of MicroRNA-92a

  28. Chen, Z, Wen, L, Martin, M, Hsu, CY, Fang, L, Lin, FM, Lin, TY, Geary, MJ, Geary, GG, Zhao, Y, Johnson, DA, Chen, JW, Lin, SJ, Chien, S, Huang, HD, Miller, YI, Huang, PH & Shyy, JYJ 2015, , Circulation, vol. 131, no. 9, pp. 805-814.

  29. 15. Zebrafish models of dyslipidemia: Relevance to atherosclerosis and angiogenesis

  30. Fang, L, Liu, C & Miller, YI 2014, , Translational Research, vol. 163, no. 2, pp. 99-108.

  31. 16. Targeted cholesterol efflux

  32. Fang, L & Miller, YI 2013, , Cell Cycle, vol. 12, no. 21, pp. 3345-3346.

  33. 17. Control of angiogenesis by AIBP-mediated cholesterol efflux

  34. Fang, L, Choi, SH, Baek, JS, Liu, C, Almazan, F, Ulrich, F, Wiesner, P, Taleb, A, Deer, E, Pattison, J, Torres-Vázquez, J, Li, AC & Miller, YI 2013, , Nature, vol. 498, no. 7452, pp. 118-122.

  35. 18. Emerging applications for zebrafish as a model organism to study oxidative mechanisms and their roles in inflammation and vascular accumulation of oxidized lipids

  36. Fang, L & Miller, YI 2012, , Free Radical Biology and Medicine, vol. 53, no. 7, pp. 1411-1420.

  37. 19. Ezetimibe and simvastatin reduce cholesterol levels in zebrafish larvae fed a high-cholesterol diet

  38. Baek, JS, Fang, L, Li, AC & Miller, YI 2012, , Cholesterol, vol. 2012, 564705.

  39. 20. In vivo visualization and attenuation of oxidized lipid accumulation in hypercholesterolemic zebrafish

  40. Fang, L, Green, SR, Baek, JS, Lee, SH, Ellett, F, Deer, E, Lieschke, GJ, Witztum, JL, Tsimikas, S & Miller, YI 2011, , Journal of Clinical Investigation, vol. 121, no. 12, pp. 4861-4869.


This guy hasn’t plasmids anything yet.

Hot plasmids


This guy has no following anyone.

Popular Cloud Scientists

Cloud Scientists

About Us · User Accounts and Benefits · Privacy Policy · Management Center · FAQs
© 2026 MolecularCloud